BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,037 filers reported holding BAXTER INTL INC in Q1 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $56,806,000 | -2.6% | 1,193,398 | -7.5% | 1.81% | -0.2% |
| Q2 2016 | $58,327,000 | -20.4% | 1,289,842 | -27.7% | 1.82% | -16.6% |
| Q1 2016 | $73,271,000 | +4.3% | 1,783,623 | -3.2% | 2.18% | +4.1% |
| Q4 2015 | $70,272,000 | +14.0% | 1,841,998 | -1.8% | 2.09% | +13.2% |
| Q3 2015 | $61,649,000 | -53.3% | 1,876,679 | -0.7% | 1.85% | -49.0% |
| Q2 2015 | $132,130,000 | +36.7% | 1,889,455 | +33.9% | 3.63% | +45.4% |
| Q1 2015 | $96,643,000 | +0.7% | 1,410,847 | +7.8% | 2.50% | -2.1% |
| Q4 2014 | $95,947,000 | -0.1% | 1,309,146 | -2.2% | 2.55% | -5.1% |
| Q3 2014 | $96,055,000 | +1.4% | 1,338,371 | +2.2% | 2.69% | +4.4% |
| Q2 2014 | $94,683,000 | +12.2% | 1,309,579 | +14.1% | 2.57% | -2.8% |
| Q1 2014 | $84,421,000 | +21.3% | 1,147,340 | +14.7% | 2.65% | +4.4% |
| Q4 2013 | $69,580,000 | -46.1% | 1,000,426 | -49.1% | 2.54% | -0.4% |
| Q3 2013 | $129,052,000 | +99.2% | 1,964,548 | +110.0% | 2.55% | -3.8% |
| Q2 2013 | $64,788,000 | – | 935,294 | – | 2.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |